Question 1

What is Altimmune, Inc. Common Stock's WACC?

Accepted Answer

Altimmune, Inc. Common Stock (ALT) has a Weighted Average Cost of Capital (WACC) of 9.70%. This is calculated using a Cost of Equity of 9.81% (via CAPM with a beta of 1.34) and a pre-tax Cost of Debt of 7.83%, with an equity weight of 94.40% in the capital structure.

Question 2

Is Altimmune, Inc. Common Stock's WACC high or low?

Accepted Answer

Altimmune, Inc. Common Stock's WACC of 9.70% falls within the typical 8-12% range for mid-cap growth companies. WACC is used as the discount rate in DCF valuations — a lower WACC results in higher present values of future cash flows.

Question 3

How is Altimmune, Inc. Common Stock's WACC calculated?

Accepted Answer

Altimmune, Inc. Common Stock's WACC is calculated using the formula: WACC = (E/V × Re) + (D/V × Rd × (1-T)). The Cost of Equity (Re) of 9.81% is derived from the CAPM model using a beta of 1.34. The pre-tax Cost of Debt (Rd) is 7.83%. The capital structure is 94.40% equity and 5.60% debt.

Altimmune, Inc. Common Stock (ALT) — WACC 分析

WACC 构成

解读

Altimmune, Inc. Common Stock（ALT）WACC：9.70%

WACC计算器

Altimmune, Inc. Common Stock（ALT） WACC 解读

ALT 公司分析

ALT DCF 估值

继续做同行对比